Feng Yu
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Animal Science and Zoology top 10%
- Animal Nutrition and Physiology
Papers in
-
- Pharmacogenetics and Drug Metabolism 4
-
- Venous Thromboembolism Diagnosis and Management 3
Feng Yu
37 papers receiving 763 citations
Peers
Comparison fields: 5 of 100
- Pharmacology 221
- Animal Science and Zoology 81
- Pharmacology 103
- Internal Medicine 21
- Cardiology and Cardiovascular Medicine 112
Countries citing papers authored by Feng Yu
This map shows the geographic impact of Feng Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Yu more than expected).
Fields of papers citing papers by Feng Yu
This network shows the impact of papers produced by Feng Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Yu. The network helps show where Feng Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Feng Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 0 | |
| 4 | 2022 | 6 | |
| 5 | 2021 | 16 | |
| 6 | 2021 | 15 | |
| 7 | 2021 | 34 | |
| 8 | 2021 | 9 | |
| 9 | 2021 | 1 | |
| 10 | 2021 | 7 | |
| 11 | 2020 | 80 | |
| 12 | 2020 | 14 | |
| 13 | 2018 | 7 | |
| 14 | 2017 | 21 | |
| 15 | 2017 | 12 | |
| 16 | Key components to consider when developing an anticoagulation clinic - a pharmacy teaching and training approach: Literature review | 2013 | 2 |
| 17 | 2012 | 43 | |
| 18 | 2012 | 22 | |
| 19 | 2011 | 91 | |
| 20 | 2009 | 27 |
About Feng Yu
Feng Yu is a scholar working on Pharmacology, Internal Medicine, Molecular Medicine, Geriatrics and Gerontology and Cardiology and Cardiovascular Medicine, having authored 41 papers that have together received 781 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (4 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers), Nephrotoxicity and Medicinal Plants (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Atrial Fibrillation Management and Outcomes (3 papers), COVID-19 Clinical Research Studies (3 papers), Venous Thromboembolism Diagnosis and Management (3 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Pharmacology (221 citations), Animal Science and Zoology (81 citations), Pharmacology (103 citations), Internal Medicine (21 citations) and Cardiology and Cardiovascular Medicine (112 citations). Feng Yu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Ji Li, Huaijun Zhu, Xiaojun Yang, Limei Yang, Weihong Ge, Junhu Yao, Xu Shen, Dongxiang Liu, Yubing Zhu and Hualiang Jiang. Their work appears in journals such as International Journal of Molecular Sciences, Medicine, Acta Pharmacologica Sinica, Poultry Science and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.